Funding News

Improving patient outcomes through the distribution of eye health supplements across African markets is the core mission of Envision Pharma Group Limited, which has just raised an estimated £614k. Bas...

Synthetic T cell-priming vaccines and immunotherapies are being developed by Gylden Pharma Limited to combat viral and bacterial infectious diseases. The Abingdon-based biotechnology company recently ...

Draig Therapeutics has secured an estimated £34.6m in a Series A funding round to advance its pipeline of next-generation neuromodulators. The Cardiff-based clinical-stage biotechnology company focuse...

Cardiaza, a patented epigenetic modifying therapy designed to treat symptomatic hypertrophic cardiomyopathy, is the primary focus of Belfast-based Signacor Therapeutics Limited following its latest fu...

Developing next-generation medicines through a quantum simulation platform, Kuano Ltd has raised an estimated £275k. The Cambridge-based company combines quantum mechanics and artificial intelligence ...

Automating the production of precision medicines is the core focus of Microfluidx Ltd, which has raised an estimated £135.7k in its latest funding round. Based in Stevenage, the company develops the C...

Wearable ultrasound devices designed to non-invasively interface with the brain are the focus of a £1.2m funding round for Neuroharmonics Ltd. The London-based company is developing a neurotechnology ...

Turbine Simulated Cell Technologies Ltd develops an AI-driven Simulated Cell platform that creates digital twins of human cells to conduct virtual experiments for drug discovery and development. Based...

Developing patented drug delivery patches to treat chronic wounds, Ebbw Vale-based Onya Therapeutics has raised an estimated £4609.9m in its latest funding round. This Series C+ investment brings the ...

Solaris Biolabs Ltd produces clinically potent crops using modular BioCube controlled-environment agriculture units. Based in Norwich, the company targets high-value ingredient markets including sport...

A first-in-class small molecule anti-fibrinolytic treatment for traumatic haemorrhage is being developed by Clotprotect Therapeutics Limited following an estimated £600k seed funding round. The Leeds-...

NunaBio Limited, a biotechnology firm based in Newcastle Upon Tyne, has raised an estimated £850k in a seed funding round. The company specializes in enzymatic technology for the synthesis, assembly, ...

Developing a proprietary platform for red blood cell-based therapeutics, Bristol-based Scarlet Therapeutics has secured an estimated £3.5m in its latest funding round. The company generates novel ther...

Digitizing the sense of smell through AI-powered sensors is the core mission of Anemo Labs Limited, which has just raised an estimated £455k. Based in London, the biotechnology research company is dev...

Programmable transcriptional editing using small molecules is the focus of Lexicon Bio, a London-based biotechnology firm that has recently secured £375k in new funding. This capital injection values ...

Precision diagnostics developer Guilford Street Laboratories has raised an estimated £1.9m to expand its AI-driven biomarker assay platform. This latest funding round values the Liverpool-based compan...

Ovo Biomanufacturing Ltd has raised an estimated £229.6k to further develop its technology for viral vaccine and gene therapy manufacturers. Based in Coventry, the company provides a software based pl...

New therapeutics for migraine and headache disorders are the primary focus of Slate Medicines UK Limited, which has raised an estimated £5.9m in its latest funding round. The Altrincham-based company ...

Astratus Limited is developing a rapid, automated antimicrobial susceptibility testing platform to provide digital results from urine or bacterial isolates in under six hours. The Reading-based compan...

Small molecule therapies designed to inhibit RNA modifying enzymes are the primary focus of Storm Therapeutics, which has raised an estimated £9.2m in new funding. Based at the Babraham Research Campu...

Digital enzyme engineering specialist Imperagen has secured an estimated £3.8m in new funding to accelerate its AI-driven protein design platform. Based in Manchester, the techbio company uses its pro...

Developing rapid diagnostic tools to combat antimicrobial resistance is the core focus of Septest Limited, which has just secured an estimated £1.1m in new funding. The Potters Bar-based company speci...

Developing a proprietary language of cancer through artificial intelligence, Glasgow-based Tilebio Ltd has secured an estimated £1.6m in new funding. The company, which was incorporated on August 6, 2...

Developing carbohydrate binding modules (CBMs) as a new therapeutic modality for cancer, Omideon Limited has secured an estimated £30k in its latest funding round. The St. Andrews based company filed ...

A London-based biotech firm specialising in carbon-absorbing textiles has raised an estimated £62k in new funding. Post Carbon Lab Ltd, which is headquartered in the E14 area of the capital, reached a...

In April 2026, we detected 20 UK Biotech equity rounds from Companies House SH01 filings. Total new shares allotted: £34.2M. Each director name links to a LinkedIn People search pre-filled with their ...

Frontier Space Technologies Ltd, a Nottingham-based innovator in the burgeoning space technology sector, has successfully closed a funding round, raising an estimated £116k. This early-stage investmen...

Invenirex Ltd, a Newcastle Upon Tyne-based biotechnology company specialising in DNA nanotechnology, has successfully secured £440,000 in a recent funding round. The allotment date for this capital in...

Smart Surgical Solutions Ltd, a London-based innovator in orthopaedic technology, has successfully closed a funding round, securing £196.9k. The investment, finalised with an allotment date of 2026-04...

Hualel Holdings Limited, a Cambridge-based company specialising in the manufacture of pharmaceutical preparations, has successfully secured an estimated £259.2k in its latest funding round. This inves...